AveXis Inc (AVXS.OQ)
Get access to over 18 million research reports from over 1,700 sources.
For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.
Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.
Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:
- private equity
- third-party document and information retrieval
- and much, much more…
Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.
|59||2016||Independent Chairman of the Board|
|49||2015||President, Chief Executive Officer, Director|
|57||2017||Principal Financial Officer, Senior Vice President, Principal Accounting Officer|
|53||2017||Chief Human Resource Officer, Senior Vice President|
|51||2016||Senior Vice President, Chief Compliance Officer, General Counsel|
- BRIEF-AveXis Announces First Patient Dosed In Phase 3 Trial Of AVXS-101 In Pre-Symptomatic SMA Types 1, 2 And 3
- BRIEF-Adage Capital Partners GP LLC Reports 6.04 Percent Stake In Avexis
- Biogen boosts investment in neurology with $1 billion Ionis deal
- Takeda sounds out banks for loans as it moves towards Shire bid: sources
- UPDATE 3-Takeda sounds out banks for loans as it moves towards Shire bid -sources